港股创新药ETF(513120)成交额超35亿元，当前涨幅为2.13%

Group 1 - The Hong Kong innovative drug ETF (513120) has a trading volume exceeding 3.5 billion yuan, with a current increase of 2.13% and a premium rate of -0.61% [1] - The trading volume reached 3.506 billion yuan, with a month-on-month increase of 28.1%, adding 257 million units to the fund [1] - This fund supports T+0 trading, allowing for same-day transactions [1]